Original news and analysis on international IP policy
The Obama administration and industry groups like the Motion Picture Association of America continue to keep their policy focus squarely on protection and enforcement of IP assets, but in testimony to the US Congress last week made no mention of multilateral venues for advancing these interests through new policy instruments.
The issue of counterfeit and substandard medicines is again not on the agenda of the World Health Organization Executive Board meeting in January, though sources say member states are being consulted about the issue by the secretariat.
The World Health Organization secretariat has released its report to the executive board meeting on pandemic influenza preparedness. A framework for handling outbreaks of potentially pandemic influenza was approved in May this year, but outstanding – and critical - elements of the framework remained unfinished.
Implementation of a United Nations-related patent pool initiative that independent reviewers say could save millions of lives (and dollars) is set to be approved next week by the initiative’s board, though some observers fear resistance from strong patent beneficiaries, such as the foundation run by Microsoft founder Bill Gates. A confidential report on the initiative prepared for board approval is expected to show multiple benefits to implementation of the pool, but also some concerns, according to informed sources.
How to handle work between meetings on creating a "legal instrument" caused a stalemate in informal negotiations at the World Intellectual Property Organization traditional knowledge committee this evening. Unable to reach agreement on the composition and activities of the group, delegates have put the negotiations on hold and will reconvene informally tomorrow (Friday) morning.
COPENHAGEN - A new draft climate change text on development and transfer of technology, obtained by Intellectual Property Watch and available to subscribers, was issued and under discussion at COP15 this afternoon.
Confidential documents related to the World Health Organization Expert Working Group on innovative financing for research and development surfaced today, revealing the group’s thinking as well as pharmaceutical industry thinking about the WHO process. The documents immediately raised concern about possible undue access to the process by industry, but the WHO told Intellectual Property Watch the industry group was not supposed to have them.
COPENHAGEN - While intellectual property rights has been ‘the elephant in the room’ in the climate change negotiations so far, officials predict that it could become the subject of heated negotiations - even at a higher political level - during the ongoing high-level meeting in Copenhagen. On the third day of the meeting, IP issues had already appeared in a proposed negotiation text.
The world’s five “major” intellectual property offices, the so-called “IP5,” have launched a website to detail their joint projects, the European Patent Office reported today. In particular, the website will document progress on ten projects agreed to last year on…
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced the appointment of a new director of intellectual property and trade, effective 7 December. Meanwhile, in the United States, new coordinator for IP enforcement has been cleared.
Daniele Dionisio argues some perspectives on health and IP might change now that controversial practices at the WTO, World Bank and IMF are increasingly under pressure, and that new government policy choices and actors on the world chessboard are emerging.
The Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge, and Folklore (IGC) at the World Intellectual Property Organization began its first meeting under a newly-minted mandate yesterday, though it seems matters of procedure may again take up much of the space for discussions, according to several delegates.